Structure-Based Drug Design

NIS Molecule

Structure-based drug design aims to identify the best compounds suitable.

Understanding how drugs interact with the proteins they are designed to target is a critical step in drug discovery. For optimum success, they must hit the right target with the expected effect to be considered safe before entering clinical trials. Structure-based drug design (SBDD) is the design and optimization of a chemical structure by structural biologists. They aim to identify the best compounds suitable for clinical testing, using knowledge of the candidate’s three-dimensional structure (3D structure) and how its shape and charge cause it to interact with its biological target.

Leverage the secrets of 3D protein structures.

Structure-based drug design (SBDD) relies on the ability to reveal the 3D structures of complex proteins. Cryo-electron microscopy (cryo-EM) can provide the requisite insights into:

  • A protein’s biological function.
  • A protein’s role in disease.
  • How drug candidates bind and interact with a protein.

NIS helps you design and optimize the best drug candidate.

Imagine gaining a comprehensive 3D structural understanding of a drug target that’s not amenable to X-ray crystallography, without needing to be an expert in a challenging field. NanoImaging Services’ deployment of cryo-EM makes this possible. We have worked with many leading pharmaceutical and biotech companies to deploy TEM, and particularly cryo-EM, in structure-based drug design. Partnering with us has enabled structural biologists to gain the information they require to perform their role at a higher level. 

We have solved over 150 3D protein structures, half of which have been challenging membrane proteins, and over 76% of datasets from our Titan Krios are below 3.5 Å. Our services are designed flexibly to help you resolve complexity.

Frequently Asked Questions

Microscopic image of structure-based drug design (SBDD)

What does SBDD stand for?

Menu Hex
NIS Mountain Hero